PHC Holdings $1.14 billion acquisition of the anatomical pathology unit of Thermo Fisher Scientific

28/1/2019

Private acquisition

Value:

$ 1.14 billion

Status:

Announced

Date:

28/1/2019

Overview:

Japan based healthcare business, PHC Holdings, has reached an agreement to acquire the anatomical pathology unit of Thermo Fisher Scientific, the largest scientific instrument manufacturer in the world, for $1.14 billion.
PHC Holdings is owned is by private equity firm KKR.

Ben Naylor - Editor

Jurisdictions:

United States
Japan
Germany

Deal type:

Private acquisition

Practice area:

M&A

Industry sectors:

Healthcare
Industrials and manufacturing

Firm:

Gleiss Lutz

Party: KKR (Acquirer)

Party: PHC Holdings Corporation (Acquirer)

Lawyers: Christian Cascante, Frank Schlobach, Jan Balssen

Related deals